CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity.
Sasha GuptaMilos SimicSharon A SaganChanelle ShepherdJason DueckerRaymond A SobelRavi DandekarGregory F WuWesley WuJohn E PakStephen L HauserWendell LimMichael R WilsonScott S ZamvilPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
In contrast to previous data showing that anti-CD19 CAR-T cell treatment exacerbated EAE, we observed that anti-CD19 CAR-T cells ameliorated EAE. In addition, anti-CD19 CAR-T cells thoroughly depleted B cells in peripheral tissues and in the CNS. However, the clinical benefit occurred independently of antigen specificity or B-cell depletion.